`Case 3:23-cv-04200-ZNQ-TJB Document 13-2 Filed 10/13/23 Page 1 of 2 PageID: 783
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`Civil Action No. 3:23-4200-ZNO-TJB
`
`Document Filed Electronica’,
`
`Se
`ACUITAS THERAPEUTICSINC.,
`|
`
`|| |
`
`Plaintiffs.
`
`Vv.
`
`ARBUTUS BIOPHARMA CORP. and
`GENEVANT SCIENCES GMBH,
`
`Defendants.
`
`
`
`DECLARATION OF NICOLAR. FELICE IN SUPPORT OF DEFENDANTS’
`MOTION TO DISMISS THE COMPLAINT
`
`I, Nicola R. Felice, pursuant to 28 U.S.C. § 1746, hereby declare as follows:
`
`1.
`
`I am an associate at the law firm of Quinn Emanuel Urquhart & Sullivan, LLP,
`
`counsel for Defendant Genevant Sciences GmbH (“Genevant”) in this action.
`
`2:
`
`I respectfully submit this declaration in support of Defendants’ Motion to Dismiss
`
`the Complaint, filed concurrently herewith, and to submit true and correct copies of certain
`
`documents.
`
`3.
`
`Attached hereto as Exhibit A is a true and correct copy ofa letter dated November
`
`23, 2020, from Genevant and Arbutus Biopharma Corporation to Pfizer Inc., with copy to BioNTech
`
`SE and BioNTech USInc.
`
`4,
`
`Attached hereto as Exhibit B is a true and correct copy ofa letter dated October
`
`12, 2021, from Genevant and Arbutus Biopharma Corporation to Pfizer Inc., with copy to BioNTech
`
`SE and BioNTech USInc.
`
`
`
`Case 3:23-cv-04200-ZNQ-TJB Document 13-2 Filed 10/13/23 Page 2 of 2 PagelD: 784
`Case 3:23-cv-04200-ZNQ-TJB Document 13-2 Filed 10/13/23 Page 2 of 2 PageID: 784
`
`5.
`
`Attached hereto as Exhibit C is a true and correct copy of an email dated June 3,
`
`2022. from Genevantand Arbutus Biopharma Corporation to BioNTech USInc., with copy to Pfizer
`
`Inc.
`
`{ declare under penalty of perjury that the foregoingis true and correct.
`
`Executed on October 13. 2023. in New York. New York.
`
`
`
`Nicola R. Felice
`
`